Welsis Corp.
Datakwaliteit: 100%
WLSS
OTC
Services
Health Services
€ 4,60
€ 0,00
(0,00%)
Marktkapitalisatie: 12,66 M
Prijs
€ 4,60
Marktkapitalisatie
12,66 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Negative free cash flow of -51.183,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,01
Interest Coverage-3,10
Waardering
PE (TTM)
-272,58
Onder sectorgemiddelde (-1,19)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Services sector mediaan (515 peers)
Sectorvergelijking
vs Services sector mediaan (515 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -272,6 | -1,2 |
| P/B | — | 1,4 |
| ROE % | — | -16,0 |
| Net Margin % | — | -18,3 |
| Rev Growth 5Y % | — | 4,2 |
| D/E | — | 0,4 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
Geen toekomstige schattingen beschikbaar
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -46.454,0 |
| ROE | N/A | ROA | -2819,67% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -51.183,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,01 |
| Interest Coverage | -3,10 | Asset Turnover | 0,00 |
| Working Capital | -81.934 | Tangible Book Value | -160.351 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -272,58 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0,40% | ||
| Market Cap | 12,66 M | Enterprise Value | 12,66 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,01 | Revenue / Share | 0,00 |
| FCF / Share | -0,02 | OCF / Share | -0,02 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 110,18% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0,0 | 2.000,0 | 15.900,0 | 0,0 |
| Net Income | -60.690,0 | -24.683,0 | -41.068,0 | -42.785,0 |
| EPS (Diluted) | -0,02 | 0,00 | 0,00 | 0,00 |
| Gross Profit | 0,0 | 2.000,0 | — | — |
| Operating Income | -50.573,0 | -57.898,0 | -41.068,0 | -42.785,0 |
| EBITDA | — | — | — | — |
| R&D Expenses | — | — | — | — |
| SG&A Expenses | — | — | — | — |
| D&A | — | — | — | — |
| Interest Expense | 10.117,0 | 6.452,0 | — | — |
| Income Tax | — | — | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 2.169,0 | 0,0 | 33.167,0 | 50.036,0 |
| Total Liabilities | 152.500,0 | 89.641,0 | 151.140,0 | 126.941,0 |
| Shareholders' Equity | -150.331,0 | -89.641,0 | -117.973,0 | -76.905,0 |
| Total Debt | — | — | — | — |
| Cash & Equivalents | — | — | — | — |
| Current Assets | 2.169,0 | 0,0 | 9.834,0 | 18.703,0 |
| Current Liabilities | 84.608,0 | 71.696,0 | 111.140,0 | 86.941,0 |
{"event":"ticker_viewed","properties":{"ticker":"WLSS","listing_kind":"stock","pathname":"/stocks/wlss","exchange":"OTC","country":"US"}}